Invention Grant
- Patent Title: Heterocyclic compound and use therefor
- Patent Title (中): 杂环化合物并用于此
-
Application No.: US14382390Application Date: 2013-02-28
-
Publication No.: US09403802B2Publication Date: 2016-08-02
- Inventor: Hiroki Sakamoto , Takahiro Sugimoto
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agency: Hamre, Schumann, Mueller & Larson, P.C.
- Priority: JP2012-047320 20120302
- International Application: PCT/JP2013/055566 WO 20130228
- International Announcement: WO2013/129622 WO 20130906
- Main IPC: C07D401/14
- IPC: C07D401/14 ; C07D209/12 ; C07D401/04 ; C07D405/12 ; C07D215/56 ; C07D401/10 ; C07D401/12 ; C07D237/28 ; C07D401/06 ; C07D403/10
Abstract:
The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity, and useful as a prophylactic or therapeutic drug for Alzheimer's disease, schizophrenia, pain, a sleep disorder and the like. The present invention relates to a compound represented by the formula (I): wherein R1 is an optionally substituted amino group or an optionally substituted cyclic amino group, R2 and R3 are each independently a hydrogen atom or a substituent, X is —CH═ or —N═, and ring A is an optionally substituted 5- to 10-membered ring, or a salt thereof.
Public/Granted literature
- US20150126487A1 HETEROCYCLIC COMPOUND AND USE THEREFOR Public/Granted day:2015-05-07
Information query
